Skyrizi and Vaginal bleeding - a phase IV clinical study of FDA data

Summary:

Vaginal bleeding is reported as a side effect among people who take Skyrizi (risankizumab-rzaa), especially for people who are 50-59 old, have been taking the drug for < 1 month also take Lexapro, and have Psoriasis.

The phase IV clinical study analyzes which people have Vaginal bleeding when taking Skyrizi. It is created by eHealthMe based on reports of 45,344 people who have side effects when taking Skyrizi from the FDA, and is updated regularly.

What is Skyrizi?

Skyrizi has active ingredients of risankizumab-rzaa. eHealthMe is studying from 45,385 Skyrizi users. Check the latest studies of Skyrizi.

What is Vaginal bleeding?

Vaginal bleeding is found to be associated with 1,154 drugs and 1,475 conditions by eHealthMe. Check the latest studies of Vaginal bleeding.

On Apr, 18, 2026

45,344 people reported to have side effects when taking Skyrizi.
Among them, 9 people (0.02%) have Vaginal bleeding.

Among these 9 people:

How long have people been on Skyrizi when they have Vaginal bleeding? *

What is the age of people who have Vaginal bleeding when taking Skyrizi? *

What are other drugs people take besides Skyrizi? *

What are other side effects people have besides Vaginal bleeding? *

Nausea (feeling of having an urge to vomit): 2 people, 22.22%
Maternal Exposure During Pregnancy (use of substance during pregnancy): 2 people, 22.22%
Abortion Spontaneous (naturally occurring miscarriage): 2 people, 22.22%
Amenorrhea (absence of a menstrual period in a woman of reproductive age): 1 person, 11.11%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 11.11%
Fatigue (feeling of tiredness): 1 person, 11.11%
Hair Loss: 1 person, 11.11%
Headache (pain in head): 1 person, 11.11%
Human Chorionic Gonadotropin Decreased: 1 person, 11.11%
Vulvovaginal Pruritus (vulvovaginal severe itching): 1 person, 11.11%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 8 people, 88.89%
Stress And Anxiety: 1 person, 11.11%
Seasonal Allergy (allergic condition due to certain season): 1 person, 11.11%
Pain: 1 person, 11.11%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 11.11%
Hypersensitivity: 1 person, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 11.11%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 11.11%
Diabetes: 1 person, 11.11%
Asthma: 1 person, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Skyrizi and have Vaginal bleeding?

- Check whether Vaginal bleeding is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Skyrizi:

Skyrizi (45,385 reports)

Vaginal bleeding treatments and more:

Vaginal bleeding (49,485 reports)

Browse all side effects of Skyrizi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vaginal bleeding:

Vaginal bleeding (1,154 drugs)

Browse all the conditions that are associated with Vaginal bleeding:

Vaginal bleeding (1,475 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on risankizumab-rzaa (the active ingredients of Skyrizi) and Skyrizi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.